CHAPTER 1. Industry Overview of Asthma Therapeutics Market
1.1. Definition and Scope
1.1.1. Definition of Asthma Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Asthma Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Asthma Therapeutics Market By Drug Class
1.2.3. Asthma Therapeutics Market By Product Type
1.2.4. Asthma Therapeutics Market By Treatment Type
1.2.5. Asthma Therapeutics Market By Route of Administration
1.2.6. Asthma Therapeutics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Asthma Therapeutics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Asthma Therapeutics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Asthma Therapeutics Market By Drug Class
4.1. Introduction
4.2. Asthma Therapeutics Market Revenue By Drug Class
4.2.1. Asthma Therapeutics Market Revenue (USD Billion) and Forecast, By Drug Class, 2020-2032
4.2.2. Bronchodilators
4.2.2.1. Bronchodilators Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Anti-Inflammatory Drugs
4.2.3.1. Anti-Inflammatory Drugs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. Combination Therapies
4.2.4.1. Combination Therapies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Asthma Therapeutics Market By Product Type
5.1. Introduction
5.2. Asthma Therapeutics Market Revenue By Product Type
5.2.1. Asthma Therapeutics Market Revenue (USD Billion) and Forecast, By Product Type, 2020-2032
5.2.2. Inhalers
5.2.2.1. Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Dry Powder Inhalers
5.2.2.2.1. Dry Powder Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Metered Dose Inhalers
5.2.2.3.1. Metered Dose Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Soft Mist Inhalers
5.2.2.4.1. Soft Mist Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Nebulizers
5.2.3.1. Nebulizers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Pneumatic Nebulizers
5.2.3.2.1. Pneumatic Nebulizers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Ultrasonic Nebulizers
5.2.3.3.1. Ultrasonic Nebulizers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.4. Mesh Nebulizers
5.2.3.4.1. Mesh Nebulizers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Asthma Therapeutics Market By Treatment Type
6.1. Introduction
6.2. Asthma Therapeutics Market Revenue By Treatment Type
6.2.1. Asthma Therapeutics Market Revenue (USD Billion) and Forecast, By Treatment Type, 2020-2032
6.2.2. Quick-Relief Medications
6.2.2.1. Quick-Relief Medications Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Long-Term Asthma Control Medications
6.2.3.1. Long-Term Asthma Control Medications Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Asthma Therapeutics Market By Route of Administration
7.1. Introduction
7.2. Asthma Therapeutics Market Revenue By Route of Administration
7.2.1. Asthma Therapeutics Market Revenue (USD Billion) and Forecast, By Route of Administration, 2020-2032
7.2.2. Inhalation
7.2.2.1. Inhalation Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Oral
7.2.3.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Parenteral
7.2.4.1. Parenteral Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Asthma Therapeutics Market By Country
8.1. North America Asthma Therapeutics Market Overview
8.2. U.S.
8.2.1. U.S. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.2.2. U.S. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
8.2.3. U.S. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
8.2.4. U.S. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
8.3. Canada
8.3.1. Canada Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
8.3.2. Canada Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
8.3.3. Canada Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
8.3.4. Canada Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Asthma Therapeutics Market By Country
9.1. Europe Asthma Therapeutics Market Overview
9.2. U.K.
9.2.1. U.K. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.2.2. U.K. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.2.3. U.K. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
9.2.4. U.K. Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.3. Germany
9.3.1. Germany Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.3.2. Germany Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.3.3. Germany Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
9.3.4. Germany Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.4. France
9.4.1. France Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.4.2. France Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.4.3. France Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
9.4.4. France Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.5. Spain
9.5.1. Spain Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.5.2. Spain Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.5.3. Spain Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
9.5.4. Spain Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
9.6.2. Rest of Europe Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
9.6.3. Rest of Europe Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
9.6.4. Rest of Europe Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Asthma Therapeutics Market By Country
10.1. Asia Pacific Asthma Therapeutics Market Overview
10.2. China
10.2.1. China Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.2.2. China Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.2.3. China Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.2.4. China Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.3. Japan
10.3.1. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.3.2. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.3.3. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.3.4. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.4. India
10.4.1. India Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.4.2. India Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.4.3. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.4.4. Japan Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.5. Australia
10.5.1. Australia Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.5.2. Australia Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.5.3. Australia Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.5.4. Australia Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.6. South Korea
10.6.1. South Korea Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.6.2. South Korea Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.6.3. South Korea Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.6.4. South Korea Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
10.7.2. Rest of Asia-Pacific Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
10.7.3. Rest of Asia-Pacific Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
10.7.4. Rest of Asia-Pacific Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Asthma Therapeutics Market By Country
11.1. Latin America Asthma Therapeutics Market Overview
11.2. Brazil
11.2.1. Brazil Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.2.2. Brazil Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.2.3. Brazil Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
11.2.4. Brazil Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.3. Mexico
11.3.1. Mexico Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.3.2. Mexico Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.3.3. Mexico Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
11.3.4. Mexico Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
11.4.2. Rest of Latin America Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
11.4.3. Rest of Latin America Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
11.4.4. Rest of Latin America Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Asthma Therapeutics Market By Country
12.1. Middle East & Africa Asthma Therapeutics Market Overview
12.2. GCC
12.2.1. GCC Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.2.2. GCC Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.2.3. GCC Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
12.2.4. GCC Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.3. South Africa
12.3.1. South Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.3.2. South Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.3.3. South Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
12.3.4. South Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Drug Class, 2020-2032
12.4.2. Rest of Middle East & Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Product Type, 2020-2032
12.4.3. Rest of Middle East & Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Treatment Type, 2020-2032
12.4.4. Rest of Middle East & Africa Asthma Therapeutics Market Revenue (USD Billion) and Forecast By Route of Administration, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Asthma Therapeutics Market
13.1. Asthma Therapeutics Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Asthma Therapeutics Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Sunovion Pharmaceuticals Inc.
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Sunovion Pharmaceuticals Inc. 2022 Asthma Therapeutics Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. GlaxoSmithKline Plc
14.3. Biogen Inc.
14.4. Teva Pharmaceutical Industries Ltd.
14.5. Amgen Inc.
14.6. Novartis International AG
14.7. F. Hoffmann-La Roche Ltd.
14.8. Boehringer Ingelheim International GmbH
14.9. AstraZeneca PLC
14.10. Merck Sharp & Dohme Corp.
14.11. Abbott Laboratories
The size of asthma therapeutics market was USD 21.6 billion in 2022.
The asthma therapeutics market CAGR during the analysis period of 2023 to 2032 is 3.6%.
The key players operating in the global asthma therapeutics market are including Sunovion Pharmaceuticals Inc., GlaxoSmithKline Plc, Biogen Inc., Teva Pharmaceutical Industries Ltd., Amgen Inc., Novartis International AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH, AstraZeneca PLC, Merck Sharp & Dohme Corp., and Abbott Laboratories.
North America region held the dominating position in asthma therapeutics industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of asthma therapeutics during the analysis period of 2023 to 2032.
The current trends and dynamics in the asthma therapeutics industry include increasing prevalence of asthma, growing awareness and healthcare expenditure, and advancements in treatment options.
The anti-inflammatory drug class held the maximum share of the asthma therapeutics industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date